Tracy Smith, MSc, PhD
Faculty Scientist, Department of Medicine, Division of Hematology and Oncology
Protocol Writer, University of Vermont Cancer Center
PRONOUNS She/Her
Firestone Medical Research Building, Room 347
149 Beaumont Ave
Larner College of Medicine
Burlington, VT 05401
United States
- Ph.D., Medical Biophysics, University of Toronto
- Regulatory Affairs Certificate: Pharmaceuticals, Regulatory Affairs Professionals Society
- MSc, Kinesiology/Physiology, University of Waterloo
University of Vermont Cancer Center
Department of Medicine, Division of Hematology and Oncology
Area(s) of expertise
- Clinical Trial Protocol Development
- Investigator-Initiated Trials (IITs)
- Regulatory Submissions (IRB, FDA/IND)
- Oncology and Translational Research
- Vascular Biology and Inflammation
- Scientific and Grant Writing
- Project and Research Operations Management
Dr. Smith's Recent Publications
Jang JW, Capaldi E, Smith TL, et al. Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis. Mol Med. 2024;30(1):128.
Smith TL, et al. eNOS controls angiogenic sprouting and retinal neovascularization through regulation of endothelial cell polarity. Cell Mol Life Sci. 2022.
BIO
Dr. Tracy L. Smith is a Faculty Scientist and Protocol Writer in the Department of Hematology/Oncology at the University of Vermont Cancer Center (UVMCC). Her work focuses on the development and regulatory management of investigator-initiated clinical trials aimed at improving cancer care and advancing translational research. In this role, Dr. Smith collaborates closely with clinical investigators to design, write, and refine IRB-ready protocol documents and regulatory submissions. She also supports pre-activation activities such as clinical trial budgeting, coverage analysis, FDA IND applications, and feasibility planning.
Prior to joining UVMCC, Dr. Smith completed postdoctoral training in vascular and molecular biology at Northwestern University, Université de Montréal, and The Hospital for Sick Children (SickKids) in Toronto. Her research explored endothelial signaling pathways involved in angiogenesis and inflammation, contributing to a deeper understanding of vascular dysfunction in disease.
Dr. Smith holds a PhD in Medical Biophysics from the University of Toronto and has authored several peer-reviewed publications in vascular biology, inflammation, and nutrition science. She currently serves as co-chair of UVMCC’s Research Activation and Evaluation (RAE) Committee and coordinates the Cancer Center’s IIT Incubator program. She is also a member of the OnCore Steering Committee, supporting system optimization and data integrity across the clinical trials enterprise. Dr. Smith brings a unique combination of scientific depth and regulatory expertise to her work in cancer clinical research.
Dr. Smith's postdoctoral training
- Vascular Biology – Northwestern University (2020–2021)
- Vascular Biology – Université de Montréal (2019–2020)
- Molecular Biology – SickKids Hospital, Toronto (2018)
Awards and Achievements
- American Heart Association Postdoctoral Fellowship (2021)
Bio
Dr. Tracy L. Smith is a Faculty Scientist and Protocol Writer in the Department of Hematology/Oncology at the University of Vermont Cancer Center (UVMCC). Her work focuses on the development and regulatory management of investigator-initiated clinical trials aimed at improving cancer care and advancing translational research. In this role, Dr. Smith collaborates closely with clinical investigators to design, write, and refine IRB-ready protocol documents and regulatory submissions. She also supports pre-activation activities such as clinical trial budgeting, coverage analysis, FDA IND applications, and feasibility planning.
Prior to joining UVMCC, Dr. Smith completed postdoctoral training in vascular and molecular biology at Northwestern University, Université de Montréal, and The Hospital for Sick Children (SickKids) in Toronto. Her research explored endothelial signaling pathways involved in angiogenesis and inflammation, contributing to a deeper understanding of vascular dysfunction in disease.
Dr. Smith holds a PhD in Medical Biophysics from the University of Toronto and has authored several peer-reviewed publications in vascular biology, inflammation, and nutrition science. She currently serves as co-chair of UVMCC’s Research Activation and Evaluation (RAE) Committee and coordinates the Cancer Center’s IIT Incubator program. She is also a member of the OnCore Steering Committee, supporting system optimization and data integrity across the clinical trials enterprise. Dr. Smith brings a unique combination of scientific depth and regulatory expertise to her work in cancer clinical research.
Dr. Smith's postdoctoral training
- Vascular Biology – Northwestern University (2020–2021)
- Vascular Biology – Université de Montréal (2019–2020)
- Molecular Biology – SickKids Hospital, Toronto (2018)
Awards and Achievements
- American Heart Association Postdoctoral Fellowship (2021)